FDA Faces Uncertain Future with Trump's Return and RFK Jr.'s Influence
Outgoing FDA Commissioner Robert Califf warns of potential upheaval as Trump prepares to appoint vaccine skeptic Robert F. Kennedy Jr. to oversee health policy.
- Robert Califf, the outgoing FDA Commissioner, expressed concerns about the direction of the agency under the new Trump administration.
- Trump has promised Robert F. Kennedy Jr., a known vaccine skeptic, a significant role in shaping public health policy.
- Califf highlighted the uncertainty and potential staff turnover at the FDA due to anticipated policy changes.
- Kennedy's controversial views on vaccines and health policy raise alarms about the future of evidence-based decision-making.
- Despite the challenges, Califf urged faith in the dedication and expertise of the FDA's workforce.